Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements - Summary Of Investments (Details)

v2.4.0.8
Fair Value Measurements - Summary Of Investments (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost $ 4,301 $ 5,335
Gross unrealized gains in Accumulated OCI 3,739 6,725
Gross unrealized losses in Accumulated OCI    0
Gain/(Loss) in Accumulated Deficit 4,022 88
Fair value 12,062 12,148
Common Stock [Member]
   
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 3,376 2,051
Gross unrealized gains in Accumulated OCI 2,698 6,185
Gross unrealized losses in Accumulated OCI 0 0
Gain/(Loss) in Accumulated Deficit      
Fair value 6,074 8,236
BZNE Note and conversion feature [Member]
   
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost   1,700
Gross unrealized gains in Accumulated OCI   53
Gross unrealized losses in Accumulated OCI   0
Gain/(Loss) in Accumulated Deficit   287
Fair value   2,040
Neovasc common stock options [Member]
   
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 925 925
Gross unrealized gains in Accumulated OCI 1,041 293
Gross unrealized losses in Accumulated OCI 0 0
Gain/(Loss) in Accumulated Deficit 4,022 176
Fair value 5,988 1,394
Neovasc common stock warrants [Member]
   
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost   659
Gross unrealized gains in Accumulated OCI   194
Gross unrealized losses in Accumulated OCI   0
Gain/(Loss) in Accumulated Deficit   (375)
Fair value   $ 478